Veru's (VERU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Jan 2, 2025 · Separately, Oppenheimer reiterated an "outperform" rating and set a $5.00 price target on shares of Veru in a research report on Tuesday, November 5th. Shares of …

$5.00
OFF

Veru's (VERU) Buy Rating Reaffirmed At HC Wainwright - MarketBeat

2 weeks from now

Jan 2, 2025 · Separately, Oppenheimer reiterated an "outperform" rating and set a $5.00 price target on shares of Veru in a research report on Tuesday, November 5th. Shares of …

marketbeat.com

$3.00
OFF

Wainwright Sustains Buy On VERU Shares On Financial Outcomes

2 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ:VERU), with a price target maintained at $3.00. Currently trading at …

investing.com

$2.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Veru (VERU)

2 weeks from now

Aug 14, 2023 · In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Veru (VERU – Research Report), with a price target of $2.00. The company’s shares …

businessinsider.com

$3.00
OFF

Strong Buy Rating For Veru Inc. On Solid Revenue Growth And …

2 weeks from now

Aug 9, 2024 · Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Veru (VERU – Research Report), retaining the price target of $3.00.. Yi Chen has given his Buy rating due to …

businessinsider.com

$3.00
OFF

Wainwright Sustains Buy On VERU Shares On Financial Outcomes

2 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ: VERU), with a price target maintained at $3.00.Currently trading at …

investing.com

$3.00
OFF

H.C. Wainwright Maintains Target On Veru Stock Post-sale

2 weeks from now

Jan 2, 2025 · On Thursday, H.C. Wainwright reaffirmed their optimistic stance on Veru Inc. (NASDAQ: VERU), maintaining a Buy rating and a price target of $3.00.Currently trading at …

investing.com

00%
OFF

Veru (VERU) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

Out of the 4 analysts, 4 have given a buy rating for VERU. Consensus Price Target. $4.00 438.00% Upside. According to the 4 ... HC Wainwright. 2 of 5 stars : Reiterated Rating: Buy …

marketbeat.com

$3.00
OFF

H.C. Wainwright Maintains Target On Veru Stock Post-sale

2 weeks from now

Jan 2, 2025 · On Thursday, H.C. Wainwright reaffirmed their optimistic stance on Veru Inc. (NASDAQ: VERU), maintaining a Buy rating and a price target of $3.00.Currently trading at …

investing.com

$0.65
OFF

Veru’s (VERU) “Buy” Rating Reaffirmed At HC Wainwright

2 weeks from now

Dec 22, 2024 · NASDAQ VERU opened at $0.65 on Friday. The firm has a market cap of $95.15 million, a price-to-earnings ratio of -1.35 and a beta of -0.50. Veru has a 12-month low of $0.36 …

etfdailynews.com

$24.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Veru (VERU) - ADVFN

2 weeks from now

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU - Research Report) today and set a price target of $24.00. The company's shares closed yesterday at $16.96.Chen …

advfn.com

$21.00
OFF

H.C. Wainwright Sticks To Their Buy Rating For Veru (VERU)

2 weeks from now

Nov 10, 2022 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU - Research Report) today and set a price target of $21.00. The companys shar...

businessinsider.com

$12.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Acurx …

2 weeks from now

3 days ago · H.C. Wainwright analyst Ed Arce reiterated a Buy rating on Acurx Pharmaceuticals (ACXP – Research Report) today and set a price target of $12.00. The company’s shares …

businessinsider.com

FAQs about Veru's (VERU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat Coupon?

Should you buy Veru (Veru – get free report)?

Veru (NASDAQ:VERU – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report issued on Friday,Benzinga reports. They presently have a $3.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 361.54% from the company’s previous close. ...

Why has Yi Chen rated Veru Inc (Vu) a buy?

Yi Chen has given his Buy rating due to a combination of factors, including the company’s recent financial performance and the potential of its pharmaceutical developments. Veru Inc. reported a higher-than-expected net revenue of $4 million, which is an 18% year-over-year growth, surpassing the projected $3 million. ...

Who owns Veru Inc?

Institutional investors own 47.16% of the company’s stock. (Get Free Report) Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). ...

Is Veru a good stock to buy?

Veru had a negative net margin of 376.38% and a negative return on equity of 115.99%. Equities analysts expect that Veru will post -0.3 earnings per share for the current fiscal year. Several institutional investors and hedge funds have recently modified their holdings of VERU. ...